桒原京子 (Kyoko Kuwahara-Arai) - マイポータル

基本情報

J-GLOBAL ID: 201801012771450462
researchmap会員ID: B000337855

論文

The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.

Dai Ishikawa, Takashi Sasaki, Masahito Takahashi, Kyoko Kuwahara-Arai, Keiichi Haga, Shoko Ito, Koki Okahara, Akihito Nakajima, Tomoyoshi Shibuya, Taro Osada …

Inflammatory bowel diseases 24(12) 2590-2598 2018年11月29日査読有り
Development of a New Application for Comprehensive Viability Analysis Based on Microbiome Analysis by Next-Generation Sequencing: Insights into Staphylococcal Carriage in Human Nasal Cavities.

Yu Jie Lu, Takashi Sasaki, Kyoko Kuwahara-Arai, Yuki Uehara, Keiichi Hiramatsu

Applied and environmental microbiology 84(11) 2018年6月1日査読有り
A new variant of 16S rRNA methylase, RmtD3, in a Clinical Isolate of Pseudomonas aeruginosa in Myanmar

Tatsuya Tada, Kayo Shimada, San Mya, Khin Nyein Zan, Kyoko Kuwahara, Teruo Kirikae, Htay Htay Tin

Antimicrobial Agents and Chemotherapy 62(1) 2018年1月1日査読有り
A Modified Carbapenem Inactivation Method, CIMTris, for Carbapenemase Production in Acinetobacter and Pseudomonas Species

Kohei Uechi, Tatsuya Tada, Kayo Shimada, Kyoko Kuwahara-Arai, Momoko Arakaki, Takaaki Tome, Isamu Nakasone, Shiro Maeda, Teruo Kirikae, Jiro Fujita

JOURNAL OF CLINICAL MICROBIOLOGY 55(12) 3405-3410 2017年12月査読有り
Antimicrobial cathelicidin peptide LL‑37 induces NET formation and suppresses the inflammatory response in a mouse septic model.

Hosoda H, Nakamura K, Hu Z, Tamura H, Reich J, Kuwahara-Arai K, Iba T, Tabe Y, Nagaoaka I

Molecular medicine reports 16(4) 5618-5626 2017年10月査読有り
Spleen-derived lipocalin-2 in the portal vein regulates Kupffer cells activation and attenuates the development of liver fibrosis in mice

Tomonori Aoyama, Kyoko Kuwahara-Arai, Akira Uchiyama, Kazuyoshi Kon, Hironao Okubo, Shunhei Yamashina, Kenichi Ikejima, Shigehiro Kokubu, Akihisa Miyazaki, Sumio Watanabe

LABORATORY INVESTIGATION 97(8) 890-902 2017年8月査読有り
Evaluation of the effect of recombinant thrombomodulin on a lipopolysaccharide-induced murine sepsis model

Kazuhiro Takehara, Taisuke Murakami, Kyoko Kuwahara-Arai, Toshiaki Iba, Isao Nagaoka, Kazuhiro Sakamoto

EXPERIMENTAL AND THERAPEUTIC MEDICINE 13(6) 2969-2974 2017年6月査読有り
Neutrophil extracellular traps induce IL-1β production by macrophages in combination with lipopolysaccharide.

Hu Z, Murakami T, Tamura H, Reich J, Kuwahara-Arai K, Iba T, Tabe Y, Nagaoka I

International journal of molecular medicine 39(3) 549-558 2017年3月査読有り
Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis

Dai Ishikawa, Takashi Sasaki, Taro Osada, Kyoko Kuwahara-Arai, Keiichi Haga, Tomoyoshi Shibuya, Keiichi Hiramatsu, Sumio Watanabe

INFLAMMATORY BOWEL DISEASES 23(1) 116-125 2017年1月査読有り
Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice

Zhongshuang Hu, Taisuke Murakami, Kaori Suzuki, Hiroshi Tamura, Johannes Reich, Kyoko Kuwahara-Arai, Toshiaki Iba, Isao Nagaoka

INTERNATIONAL IMMUNOLOGY 28(5) 245-253 2016年5月査読有り
Human Host Defense Cathelicidin Peptide LL-37 Enhances the Lipopolysaccharide Uptake by Liver Sinusoidal Endothelial Cells without Cell Activation

Kaori Suzuki, Taisuke Murakami, Zhongshuang Hu, Hiroshi Tamura, Kyoko Kuwahara-Arai, Toshiaki Iba, Isao Nagaoka

JOURNAL OF IMMUNOLOGY 196(3) 1338-1347 2016年2月査読有り
Complete genome sequence of methicillin-resistant Staphylococcus schleiferi strain TSCC54 of canine origin

Takashi Sasaki, Sae Tsubakishita, Kyoko Kuwahara-Arai, Miki Matsuo, Yu Jie Lu, Yoshikazu Tanaka, Keiichi Hiramatsu

Genome Announcements 3(5) 2015年査読有り
"Slow VISA," a Novel Phenotype of Vancomycin Resistance, Found In Vitro in Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strain Mu3

Michie Saito, Yuki Katayama, Tomomi Hishinuma, Akira Iwamoto, Yoshifumi Aiba, Kyoko Kuwahara-Arai, Longzhu Cui, Miki Matsuo, Nanae Aritaka, Keiichi Hiramatsua

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 58(9) 5024-5035 2014年9月査読有り
Staphylococcal Cassette Chromosome mec (SCCmec) analysis of MRSA.

Teruyo Ito, Kyoko Kuwahara-Arai, Yuki Katayama, Yuki Uehara, Xiao Han, Yoko Kondo, Keiichi Hiramatsu

Methods in molecular biology (Clifton, N.J.) 1085 131-48 2014年査読有り
Antimicrobial Cathelicidin Peptide LL-37 Inhibits the LPS/ATP-Induced Pyroptosis of Macrophages by Dual Mechanism

Zhongshuang Hu, Taisuke Murakami, Kaori Suzuki, Hiroshi Tamura, Kyoko Kuwahara-Arai, Toshiaki Iba, Isao Nagaoka

PLOS ONE 9(1) e85765 2014年1月査読有り
Genomic basis for methicillin resistance in Staphylococcus aureus

Keiichi Hiramatsu, Teruyo Ito, Sae Tsubakishita, Takashi Sasaki, Fumihiko Takeuchi, Yuh Morimoto, Yuki Katayama, Miki Matsuo, Kyoko Kuwahara-Arai, Tomomi Hishinuma …

Infection and Chemotherapy 45(2) 117-136 2013年査読有り
Rapid and Accurate Identification of Human-Associated Staphylococci by Use of Multiplex PCR

Shintaro Hirotaki, Takashi Sasaki, Kyoko Kuwahara-Arai, Keiichi Hiramatsu

JOURNAL OF CLINICAL MICROBIOLOGY 49(10) 3627-3631 2011年10月査読有り
Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells

Kaori Suzuki, Taisuke Murakami, Kyoko Kuwahara-Arai, Hiroshi Tamura, Keiichi Hiramatsu, Isao Nagaoka

INTERNATIONAL IMMUNOLOGY 23(3) 185-193 2011年3月査読有り
Transcription and Translation Products of the Cytolysin Gene psm-mec on the Mobile Genetic Element SCCmec Regulate Staphylococcus aureus Virulence

Chikara Kaito, Yuki Saito, Gentaro Nagano, Mariko Ikuo, Yosuke Omae, Yuichi Hanada, Xiao Han, Kyoko Kuwahara-Arai, Tomomi Hishinuma, Tadashi Baba …

PLOS PATHOGENS 7(2) e1001267 2011年2月査読有り
Origin and Molecular Evolution of the Determinant of Methicillin Resistance in Staphylococci

Sae Tsubakishita, Kyoko Kuwahara-Arai, Takashi Sasaki, Keiichi Hiramatsu

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 54(10) 4352-4359 2010年10月査読有り

もっとみる

MISC

温水洗浄便座で生成した次亜塩素酸水の緑膿菌に対する除菌効果

伊丹愛子, 桒原京子, 堀賢

日本環境感染学会誌 33(2) 47-51 2018年
温水洗浄便座洗浄ノズルの除菌条件の検討

桒原京子, 左卉, 堀賢

日本環境感染学会誌 32(3) 127-130 2017年
Meropenem, its in vitro antibacterial activity and biological stability

Takeshi Yokota, Eiko Suzuki, Kyoko Arai

CHEMOTHERAPY 40 30-40 1992年
In vitro antibacterial activity of levofloxacin, its selective toxicity and influence on axon dendrites

Takeshi Yokota, Eiko Suzuki, Kyoko Arai, Kayoko Kanda

CHEMOTHERAPY 40 27-35 1992年
In vitro antibacterial activity of sparfloxacin, its synergy with the complement or mouse cultured macrophages (MØ) in the bactericidal effect, and cytotoxicity to mammalian cells

Takeshi Yokota, Kayoko Kanda, Kyoko Arai

CHEMOTHERAPY 39 30-36 1991年
Cefpirome, its in vitro antibacterial activity, binding affinity to the site of action, pbps, and synergy of bactericidal effect with serum complement or mouse cultured macrophages

Takeshi Yokota, Kyoko Arai, Eiko Suzuki, Toshiyuki Nehashi

CHEMOTHERAPY 39 11-20 1991年
Cefepime, its in vitro antibacterial activity, affinity to penicillin binding proteins (PBP<inf>s</inf>), synergy with complement or mouse cultured macrophages (Mɸ) in producing its bactericidal effect

Takeshi Yokota, Chieko Jin, Kyoko Arai

Chemotherapy 39 20-27 1991年
Cefetamet, the active form of cefetamet pivoxil; its in vitro antibacterial activity, affinity to bacterial PBP<inf>S</inf>, and synergy of bactericidal effect with the complement or mouse cultured macrophages (mφ)

Takeshi Yokota, Eiko Suzuki, Kyoko Arai

CHEMOTHERAPY 38 12-20 1990年
Fleroxacin, its in vitro antibacterial activity, synergy of bactericidal effect with serum complement or mouse cultured macrophages (mφ), cytostatic activity in mammalian cells, and influence on extension of axon dendrites of redifferentiated human neurob

Takeshi Yokota, Eiko Suzuki, Kyoko Arai, Kayoko Kanda

CHEMOTHERAPY 38 26-33 1990年
BMY-28100, ITS in vitro antibacterial activity, binding affinity to bacterial pbps, and synergy of bactericidal effect with serum complement and mouse cultured macrophages (Mφ)

Takeshi Yokota, Chieko Jin, Eiko Suzuki, Kyoko Arai

CHEMOTHERAPY 37 16-34 1989年
Cefdinir, its in vitro antibacterial activity, binding affinity to bacterial PBPs, stability to, β-lactamases, and synergy of bactericidal effect with serum complement and mouse cultured macrophages

Takeshi Yokota, Eiko Suzuki, Kyoko Arai

CHEMOTHERAPY 37 16-29 1989年
7432-S, its in vitro antibacterial activity, affinity with bacterial penicillin-binding proteins (PBPs), and synergy of bactericidal effect with the serum complement or mouse cultured macrophages

Takeshi Yokota, Eiko Suzuki, Kyoko Arai

CHEMOTHERAPY 37 33-43 1989年
TE-031 (A-56268). A new macrolide, its in vitro antibacterial activity, synergy of bactericidal effect with serum complement and mouse cultured macrophages, and incorporation into leucocytes

Takeshi Yokota, Eiko Suzuki, Kyoko Arai

CHEMOTHERAPY 36 59-70 1988年
Ny-198, A novel new quinolone: Its in vitro antibacterial activity, cytotoxicity for mammalian cells, and synergy of bactericidal activity with mouse-cultured macrophages

Takeshi Yokota, Eiko Suzuki, Kyoko Arai

CHEMOTHERAPY 36 25-35 1988年
CS-807, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins (PBPs), and synergy of bactericidal activity with the serum complement and mouse-cultured macrophages

Takeshi Yokota, Eiko Suzuki, Kyoko Arai

CHEMOTHERAPY 36 16-26 1988年
T-3262, A new quinolone derivative: Its in vitro antibacterial activity, influence of serum protein on the activity, cytotoxicity, and synergy of bactericidal effect with mouse cultured macrophages

Takeshi Yokota, Eiko Suzuki, Kyoko Arai, Kayoko Kanda

CHEMOTHERAPY 36 19-29 1988年
Cefotiam hexetil, A new oral cephalosporin; binding affinity to penicillin-binding proteins and synergistic effect on phagocytosis and killing of bacteria with culture macrophages

Takeshi Yokota, Kyoko Arai, Eiko Suzuki

CHEMOTHERAPY 36 37-45 1988年
A combination drug of sulbactam and ampicillin (SBT·ABPC): In vitro antibacterial activity, binding-affinity to bacterial penicillin-binding proteins (PBPs), and effect on bacterial morphology

Takeshi Yokota, Eiko Suzuki, Kyoko Arai, Kenji Kawasaki

CHEMOTHERAPY 36 1-12 1988年
Cefodizime (THR-221), its in vitro antibacterial activity, binding affinity to bacterial PBPs, and synergy of bactericidal activity with complement and mouse cultured macrophages

Takeshi Yokota, Ryushi Nozawa, Eiko Suzuki, Kyoko Arai

CHEMOTHERAPY 36 60-76 1988年
In vitro antibacterial activity of the semi-synthetic macrolide, RU 28965: Synergy with serum, complement, and lysozyme; synergistic phagocytic effect with leucocytes

Ken Yokota, I. Bhatacharyya, Eiko Suzuki, Kyoko Arai

CHEMOTHERAPY 36 35-52 1988年

もっとみる